Global Psoriatic Arthritis (PsA) Treatment Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 306978
  • calendar_today Published On: Jun, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Psoriatic Arthritis (PsA) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Psoriatic Arthritis (PsA) Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Psoriatic Arthritis (PsA) Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Nonsteriodal Anti-inflammatory Drugs segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Psoriatic Arthritis (PsA) Treatment include Pfizer, Johnson & Johnson, AbbVie, Novartis, and UCB, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Psoriatic Arthritis (PsA) Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Nonsteriodal Anti-inflammatory Drugs

Disease Modifying Antirheumatic Drugs

Biologics

Market segment by Application, can be divided into

Hospitals

Clinics

Others

Market segment by players, this report covers

Pfizer

Johnson & Johnson

AbbVie

Novartis

UCB

Roche

Bristol-Myers Squibb

Eli Lilly

Amgen

AstraZeneca

Celgene

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Psoriatic Arthritis (PsA) Treatment product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Psoriatic Arthritis (PsA) Treatment, with revenue, gross margin and global market share of Psoriatic Arthritis (PsA) Treatment from 2019 to 2022.

Chapter 3, the Psoriatic Arthritis (PsA) Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Psoriatic Arthritis (PsA) Treatment market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Psoriatic Arthritis (PsA) Treatment research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Psoriatic Arthritis (PsA) Treatment

1.2 Classification of Psoriatic Arthritis (PsA) Treatment by Type

1.2.1 Overview: Global Psoriatic Arthritis (PsA) Treatment Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type in 2021

1.2.3 Nonsteriodal Anti-inflammatory Drugs

1.2.4 Disease Modifying Antirheumatic Drugs

1.2.5 Biologics

1.3 Global Psoriatic Arthritis (PsA) Treatment Market by Application

1.3.1 Overview: Global Psoriatic Arthritis (PsA) Treatment Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Psoriatic Arthritis (PsA) Treatment Market Size & Forecast

1.5 Global Psoriatic Arthritis (PsA) Treatment Market Size and Forecast by Region

1.5.1 Global Psoriatic Arthritis (PsA) Treatment Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Psoriatic Arthritis (PsA) Treatment Market Size by Region, (2017-2022)

1.5.3 North America Psoriatic Arthritis (PsA) Treatment Market Size and Prospect (2017-2028)

1.5.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size and Prospect (2017-2028)

1.5.6 South America Psoriatic Arthritis (PsA) Treatment Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Psoriatic Arthritis (PsA) Treatment Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Psoriatic Arthritis (PsA) Treatment Market Drivers

1.6.2 Psoriatic Arthritis (PsA) Treatment Market Restraints

1.6.3 Psoriatic Arthritis (PsA) Treatment Trends Analysis

2 Company Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Product and Solutions

2.1.4 Pfizer Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Pfizer Recent Developments and Future Plans

2.2 Johnson & Johnson

2.2.1 Johnson & Johnson Details

2.2.2 Johnson & Johnson Major Business

2.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product and Solutions

2.2.4 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Johnson & Johnson Recent Developments and Future Plans

2.3 AbbVie

2.3.1 AbbVie Details

2.3.2 AbbVie Major Business

2.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Product and Solutions

2.3.4 AbbVie Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 AbbVie Recent Developments and Future Plans

2.4 Novartis

2.4.1 Novartis Details

2.4.2 Novartis Major Business

2.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Product and Solutions

2.4.4 Novartis Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Novartis Recent Developments and Future Plans

2.5 UCB

2.5.1 UCB Details

2.5.2 UCB Major Business

2.5.3 UCB Psoriatic Arthritis (PsA) Treatment Product and Solutions

2.5.4 UCB Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 UCB Recent Developments and Future Plans

2.6 Roche

2.6.1 Roche Details

2.6.2 Roche Major Business

2.6.3 Roche Psoriatic Arthritis (PsA) Treatment Product and Solutions

2.6.4 Roche Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Roche Recent Developments and Future Plans

2.7 Bristol-Myers Squibb

2.7.1 Bristol-Myers Squibb Details

2.7.2 Bristol-Myers Squibb Major Business

2.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product and Solutions

2.7.4 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.8 Eli Lilly

2.8.1 Eli Lilly Details

2.8.2 Eli Lilly Major Business

2.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Product and Solutions

2.8.4 Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Eli Lilly Recent Developments and Future Plans

2.9 Amgen

2.9.1 Amgen Details

2.9.2 Amgen Major Business

2.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Product and Solutions

2.9.4 Amgen Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Amgen Recent Developments and Future Plans

2.10 AstraZeneca

2.10.1 AstraZeneca Details

2.10.2 AstraZeneca Major Business

2.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Product and Solutions

2.10.4 AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 AstraZeneca Recent Developments and Future Plans

2.11 Celgene

2.11.1 Celgene Details

2.11.2 Celgene Major Business

2.11.3 Celgene Psoriatic Arthritis (PsA) Treatment Product and Solutions

2.11.4 Celgene Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Celgene Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Psoriatic Arthritis (PsA) Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Psoriatic Arthritis (PsA) Treatment Players Market Share in 2021

3.2.2 Top 10 Psoriatic Arthritis (PsA) Treatment Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Psoriatic Arthritis (PsA) Treatment Players Head Office, Products and Services Provided

3.4 Psoriatic Arthritis (PsA) Treatment Mergers & Acquisitions

3.5 Psoriatic Arthritis (PsA) Treatment New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Psoriatic Arthritis (PsA) Treatment Revenue and Market Share by Type (2017-2022)

4.2 Global Psoriatic Arthritis (PsA) Treatment Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Application (2017-2022)

5.2 Global Psoriatic Arthritis (PsA) Treatment Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Psoriatic Arthritis (PsA) Treatment Revenue by Type (2017-2028)

6.2 North America Psoriatic Arthritis (PsA) Treatment Revenue by Application (2017-2028)

6.3 North America Psoriatic Arthritis (PsA) Treatment Market Size by Country

6.3.1 North America Psoriatic Arthritis (PsA) Treatment Revenue by Country (2017-2028)

6.3.2 United States Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

6.3.3 Canada Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

6.3.4 Mexico Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Psoriatic Arthritis (PsA) Treatment Revenue by Type (2017-2028)

7.2 Europe Psoriatic Arthritis (PsA) Treatment Revenue by Application (2017-2028)

7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Country

7.3.1 Europe Psoriatic Arthritis (PsA) Treatment Revenue by Country (2017-2028)

7.3.2 Germany Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

7.3.3 France Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

7.3.5 Russia Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

7.3.6 Italy Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue by Type (2017-2028)

8.2 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue by Application (2017-2028)

8.3 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Market Size by Region

8.3.1 Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue by Region (2017-2028)

8.3.2 China Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

8.3.3 Japan Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

8.3.4 South Korea Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

8.3.5 India Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

8.3.7 Australia Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Psoriatic Arthritis (PsA) Treatment Revenue by Type (2017-2028)

9.2 South America Psoriatic Arthritis (PsA) Treatment Revenue by Application (2017-2028)

9.3 South America Psoriatic Arthritis (PsA) Treatment Market Size by Country

9.3.1 South America Psoriatic Arthritis (PsA) Treatment Revenue by Country (2017-2028)

9.3.2 Brazil Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

9.3.3 Argentina Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Revenue by Type (2017-2028)

10.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Revenue by Application (2017-2028)

10.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Country

10.3.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Revenue by Country (2017-2028)

10.3.2 Turkey Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

10.3.4 UAE Psoriatic Arthritis (PsA) Treatment Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Psoriatic Arthritis (PsA) Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Psoriatic Arthritis (PsA) Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Psoriatic Arthritis (PsA) Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Psoriatic Arthritis (PsA) Treatment Revenue (USD Million) by Region (2017-2022)

Table 5. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Region (2023-2028)

Table 6. Pfizer Corporate Information, Head Office, and Major Competitors

Table 7. Pfizer Major Business

Table 8. Pfizer Psoriatic Arthritis (PsA) Treatment Product and Solutions

Table 9. Pfizer Psoriatic Arthritis (PsA) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 11. Johnson & Johnson Major Business

Table 12. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Product and Solutions

Table 13. Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. AbbVie Corporate Information, Head Office, and Major Competitors

Table 15. AbbVie Major Business

Table 16. AbbVie Psoriatic Arthritis (PsA) Treatment Product and Solutions

Table 17. AbbVie Psoriatic Arthritis (PsA) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Novartis Corporate Information, Head Office, and Major Competitors

Table 19. Novartis Major Business

Table 20. Novartis Psoriatic Arthritis (PsA) Treatment Product and Solutions

Table 21. Novartis Psoriatic Arthritis (PsA) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. UCB Corporate Information, Head Office, and Major Competitors

Table 23. UCB Major Business

Table 24. UCB Psoriatic Arthritis (PsA) Treatment Product and Solutions

Table 25. UCB Psoriatic Arthritis (PsA) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Roche Corporate Information, Head Office, and Major Competitors

Table 27. Roche Major Business

Table 28. Roche Psoriatic Arthritis (PsA) Treatment Product and Solutions

Table 29. Roche Psoriatic Arthritis (PsA) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 31. Bristol-Myers Squibb Major Business

Table 32. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Product and Solutions

Table 33. Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 35. Eli Lilly Major Business

Table 36. Eli Lilly Psoriatic Arthritis (PsA) Treatment Product and Solutions

Table 37. Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Amgen Corporate Information, Head Office, and Major Competitors

Table 39. Amgen Major Business

Table 40. Amgen Psoriatic Arthritis (PsA) Treatment Product and Solutions

Table 41. Amgen Psoriatic Arthritis (PsA) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 43. AstraZeneca Major Business

Table 44. AstraZeneca Psoriatic Arthritis (PsA) Treatment Product and Solutions

Table 45. AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Celgene Corporate Information, Head Office, and Major Competitors

Table 47. Celgene Major Business

Table 48. Celgene Psoriatic Arthritis (PsA) Treatment Product and Solutions

Table 49. Celgene Psoriatic Arthritis (PsA) Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Global Psoriatic Arthritis (PsA) Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 51. Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 52. Breakdown of Psoriatic Arthritis (PsA) Treatment by Company Type (Tier 1, Tier 2 and Tier 3)

Table 53. Psoriatic Arthritis (PsA) Treatment Players Head Office, Products and Services Provided

Table 54. Psoriatic Arthritis (PsA) Treatment Mergers & Acquisitions in the Past Five Years

Table 55. Psoriatic Arthritis (PsA) Treatment New Entrants and Expansion Plans

Table 56. Global Psoriatic Arthritis (PsA) Treatment Revenue (USD Million) by Type (2017-2022)

Table 57. Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Type (2017-2022)

Table 58. Global Psoriatic Arthritis (PsA) Treatment Revenue Forecast by Type (2023-2028)

Table 59. Global Psoriatic Arthritis (PsA) Treatment Revenue by Application (2017-2022)

Table 60. Global Psoriatic Arthritis (PsA) Treatment Revenue Forecast by Application (2023-2028)

Table 61. North America Psoriatic Arthritis (PsA) Treatment Revenue by Type (2017-2022) & (USD Million)

Table 62. North America Psoriatic Arthritis (PsA) Treatment Revenue by Type (2023-2028) & (USD Million)

Table 63. North America Psoriatic Arthritis (PsA) Treatment Revenue by Application (2017-2022) & (USD Million)

Table 64. North America Psoriatic Arthritis (PsA) Treatment Revenue by Application (2023-2028) & (USD Million)

Table 65. North America Psoriatic Arthritis (PsA) Treatment Revenue by Country (2017-2022) & (USD Million)

Table 66. North America Psoriatic Arthritis (PsA) Treatment Revenue by Country (2023-2028) & (USD Million)

Table 67. Europe Psoriatic Arthritis (PsA) Treatment Revenue by Type (2017-2022) & (USD Million)

Table 68. Europe Psoriatic Arthritis (PsA) Treatment Revenue by Type (2023-2028) & (USD Million)

Table 69. Europe Psoriatic Arthritis (PsA) Treatment Revenue by Application (2017-2022) & (USD Million)

Table 70. Europe Psoriatic Arthritis (PsA) Treatment Revenue by Application (2023-2028) & (USD Million)

Table 71. Europe Psoriatic Arthritis (PsA) Treatment Revenue by Country (2017-2022) & (USD Million)

Table 72. Europe Psoriatic Arthritis (PsA) Treatment Revenue by Country (2023-2028) & (USD Million)

Table 73. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue by Type (2017-2022) & (USD Million)

Table 74. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue by Type (2023-2028) & (USD Million)

Table 75. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue by Application (2017-2022) & (USD Million)

Table 76. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue by Application (2023-2028) & (USD Million)

Table 77. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue by Region (2017-2022) & (USD Million)

Table 78. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue by Region (2023-2028) & (USD Million)

Table 79. South America Psoriatic Arthritis (PsA) Treatment Revenue by Type (2017-2022) & (USD Million)

Table 80. South America Psoriatic Arthritis (PsA) Treatment Revenue by Type (2023-2028) & (USD Million)

Table 81. South America Psoriatic Arthritis (PsA) Treatment Revenue by Application (2017-2022) & (USD Million)

Table 82. South America Psoriatic Arthritis (PsA) Treatment Revenue by Application (2023-2028) & (USD Million)

Table 83. South America Psoriatic Arthritis (PsA) Treatment Revenue by Country (2017-2022) & (USD Million)

Table 84. South America Psoriatic Arthritis (PsA) Treatment Revenue by Country (2023-2028) & (USD Million)

Table 85. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Revenue by Type (2017-2022) & (USD Million)

Table 86. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Revenue by Type (2023-2028) & (USD Million)

Table 87. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Revenue by Application (2017-2022) & (USD Million)

Table 88. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Revenue by Application (2023-2028) & (USD Million)

Table 89. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Revenue by Country (2017-2022) & (USD Million)

Table 90. Middle East & Africa Psoriatic Arthritis (PsA) Treatment Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Psoriatic Arthritis (PsA) Treatment Picture

Figure 2. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Type in 2021

Figure 3. Nonsteriodal Anti-inflammatory Drugs

Figure 4. Disease Modifying Antirheumatic Drugs

Figure 5. Biologics

Figure 6. Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Application in 2021

Figure 7. Hospitals Picture

Figure 8. Clinics Picture

Figure 9. Others Picture

Figure 10. Global Psoriatic Arthritis (PsA) Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 11. Global Psoriatic Arthritis (PsA) Treatment Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Region (2017-2028)

Figure 13. Global Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Region in 2021

Figure 14. North America Psoriatic Arthritis (PsA) Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Europe Psoriatic Arthritis (PsA) Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. South America Psoriatic Arthritis (PsA) Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Psoriatic Arthritis (PsA) Treatment Market Drivers

Figure 20. Psoriatic Arthritis (PsA) Treatment Market Restraints

Figure 21. Psoriatic Arthritis (PsA) Treatment Market Trends

Figure 22. Pfizer Recent Developments and Future Plans

Figure 23. Johnson & Johnson Recent Developments and Future Plans

Figure 24. AbbVie Recent Developments and Future Plans

Figure 25. Novartis Recent Developments and Future Plans

Figure 26. UCB Recent Developments and Future Plans

Figure 27. Roche Recent Developments and Future Plans

Figure 28. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 29. Eli Lilly Recent Developments and Future Plans

Figure 30. Amgen Recent Developments and Future Plans

Figure 31. AstraZeneca Recent Developments and Future Plans

Figure 32. Celgene Recent Developments and Future Plans

Figure 33. Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Players in 2021

Figure 34. Psoriatic Arthritis (PsA) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 35. Global Top 3 Players Psoriatic Arthritis (PsA) Treatment Revenue Market Share in 2021

Figure 36. Global Top 10 Players Psoriatic Arthritis (PsA) Treatment Revenue Market Share in 2021

Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 38. Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Type in 2021

Figure 39. Global Psoriatic Arthritis (PsA) Treatment Market Share Forecast by Type (2023-2028)

Figure 40. Global Psoriatic Arthritis (PsA) Treatment Revenue Share by Application in 2021

Figure 41. Global Psoriatic Arthritis (PsA) Treatment Market Share Forecast by Application (2023-2028)

Figure 42. North America Psoriatic Arthritis (PsA) Treatment Sales Market Share by Type (2017-2028)

Figure 43. North America Psoriatic Arthritis (PsA) Treatment Sales Market Share by Application (2017-2028)

Figure 44. North America Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Country (2017-2028)

Figure 45. United States Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Canada Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Mexico Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Europe Psoriatic Arthritis (PsA) Treatment Sales Market Share by Type (2017-2028)

Figure 49. Europe Psoriatic Arthritis (PsA) Treatment Sales Market Share by Application (2017-2028)

Figure 50. Europe Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Country (2017-2028)

Figure 51. Germany Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. France Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. United Kingdom Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. Russia Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Italy Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Sales Market Share by Type (2017-2028)

Figure 57. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Sales Market Share by Application (2017-2028)

Figure 58. Asia-Pacific Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Region (2017-2028)

Figure 59. China Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Japan Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. South Korea Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. India Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Southeast Asia Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Australia Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. South America Psoriatic Arthritis (PsA) Treatment Sales Market Share by Type (2017-2028)

Figure 66. South America Psoriatic Arthritis (PsA) Treatment Sales Market Share by Application (2017-2028)

Figure 67. South America Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Country (2017-2028)

Figure 68. Brazil Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Argentina Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Sales Market Share by Type (2017-2028)

Figure 71. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Sales Market Share by Application (2017-2028)

Figure 72. Middle East and Africa Psoriatic Arthritis (PsA) Treatment Revenue Market Share by Country (2017-2028)

Figure 73. Turkey Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Saudi Arabia Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. UAE Psoriatic Arthritis (PsA) Treatment Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Methodology

Figure 77. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz